Benzinga | Jan 11, 2021 07:05AM EST

Thermo Fisher Scientific Inc Expects Q4 Reported And Organic Revenue Growth Of Approximately 50%

From Co. Filing:

As previously announced, Marc N. Casper, Chairman, President and Chief Executive Officer of Thermo Fisher Scientific Inc. (the "Company"), will present virtually today at the 39th Annual J.P. Morgan Healthcare Conference. Among other topics, Mr. Casper will provide the Company's current perspective on the impact of the COVID-19 pandemic and an update on expected revenue growth. Based on currently available information, the Company now expects fourth quarter reported and organic revenue1 growth of approximately 50%, compared to the expected fourth quarter organic revenue growth of 40% that the Company provided on December 1, 2020, when Mr. Casper participated in a virtual fireside chat at the Evercore ISI HealthCONx Conference. This would translate to full year 2020 reported and organic revenue growth of approximately 25%, compared to the expected full year 2020 organic revenue growth of approximately 22% that the Company also provided on December 1, 2020. Details will be provided on the Company's earnings conference call for the fourth quarter and full year 2020 on February 1, 2021.



The information contained in Item 2.02 of this Form 8-K shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such a filing.